Drug Trial Radar · NCT05156983
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Last checked: Nov 19, 2026Latest source record: Jun 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
440
Planned (sponsor's estimate)
Start
Aug 24, 2022
Primary completion
Aug 30, 2028
Study completion Aug 30, 2028
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Takeda Development Center Americas, Inc.
- First posted
- Dec 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagulation reversal in participants treated with Factor Xa inhibitors who require urgent surgery/invasive procedure. The participant will be assigned by chance to either TAK-330 or SOC 4F-PCC as part of standard treatment before surgery. Patients participating in this study will need to be hospitalized. They will also be contacted (via telehealth/phone call) 30 days after the surgery.
Conditions
- Coagulation Disorder
Interventions
TAK-330Drug
Participants will receive TAK-330, 25 IU/kg single intravenous infusion on Day 1 and an additional dose of 25 IU/kg TAK-330 can be administered if required.
SOC 4F-PCCDrug
Participants will receive 4F-PCC as SOC on Day 1. The dose and infusion speed of the SOC 4F-PCC will be based on local institutional protocols. An additional dose of SOC 4F-PCC not exceeding total dose of 50 IU/kg or 5,000 IU, whichever is smaller can be given during the surgery if required.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Intraoperative Effective HemostasisTime frame: At the end of the surgery/procedure
Locations
64 sites in 15 countries. Site status is shown where the registry gives one.
University of Arkansas Medical Sciences
Arkansas City, Arkansas · Recruiting
University of California Davis Health System
Sacramento, California · Recruiting
Denver Metro Orthopedics, P.C.
Englewood, Colorado · Recruiting
University of Florida
Gainesville, Florida · Recruiting
Rutgers, The State University of New Jersey
New Brunswick, New Jersey · Recruiting
ECU Health Medical Center
Greenville, North Carolina · Recruiting
Metro Health Medical Center
Cleveland, Ohio · Recruiting
Ohio State University
Columbus, Ohio · Recruiting
Ascension St. John Medical Center
Tulsa, Oklahoma · Recruiting
University of Pennsylvania - Perelman School of Medicine
Philadelphia, Pennsylvania · Recruiting
UPMC
Pittsburgh, Pennsylvania · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Carilion Medical Center
Virginia Beach, Virginia · Recruiting
Hospital Universitario Austral
Buenos Aires, Argentina · Recruiting
Clinica Zabala
Ciudad Autonoma Buenos Aires, Argentina · Recruiting
Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia - FLENI
Ciudad Autonoma Buenos Aires, Argentina · Recruiting
Hospital Privado de Rosario
Santa Fe, Argentina · Recruiting
LKH - Universitaetsklinikum Graz
Graz, Austria · Recruiting
Landesklinikum Neunkirchen
Neunkirchen, Austria · Recruiting
AZ Groeninge
Kortrijk, Belgium · Recruiting
CHU UCL Namur
Therasse 1, Belgium · Recruiting
ZOL
Genk, Limburg, Belgium · Recruiting
Jessa Ziekenhuis Hospital
Hasselt, Limburg, Belgium · Recruiting
Hospital de Clinicas de Ijui
Ijuí, Brazil · Recruiting
Hospital Sao Paulo
São Paulo, Brazil · Recruiting
Irmandade da Santa Casa da Misericordia de Santos
Santos, São Paulo, Brazil · Recruiting
The Ottawa Hospital - General Campus
Ontario, Canada · Recruiting
CHU de Quebec- Hopital de l Enfant Jesus
Québec, Canada · Recruiting
Hamilton General Hospital
Hamilton, Ontario, Canada · Recruiting
London Health Sciences Centre (LHSC) - University Hospital
London, Ontario, Canada · Recruiting
Unity Health Toronto St Michaels Hospital
Toronto, Ontario, Canada · Recruiting
Montreal General Hospital
Montreal, Quebec, Canada · Recruiting
Fakultni nemocnice Brno
Jihlavska, Czechia · Recruiting
Fakultni nemocnice v Motole
Prague (Praha), Czechia · Recruiting
Dept of II. interni klinika - gastroenterologie
Srobarova C, Czechia · Recruiting
Hospital michallon - CHUGA
Grenoble, France · Completed
Hopital Marie Lannelongue
Le Plessis-Robinson, France · Completed
Hôpital Lariboisière
Paris, France · Completed
GH Paris Saint Joseph
Paris, France · Recruiting
CHU Strasbourg - Hopital Hautepierre
Strasbourg, Bas Rhin, France · Recruiting
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.